Effectiveness of second-generation antipsychotics with acute-phase schizophrenia

Schizophrenia Research

Volumn 113, Issue 1, 2009, Pages 49-55

  Hatta, Kotaro ^a   Sato, Koji ^b   Hamakawa, Hiroshi ^c   Takebayashi, Hiroshi ^d   Kimura, Naoto ^e   Ochi, Shinichiro ^e   Sudo, Yasuhiko ^f   Asukai, Nozomu ^g   Nakamura, Hiroyuki ^h   Usui, Chie ^a   Kawabata, Toshitaka ⁱ   Hirata, Toyoaki ^j   Sawa, Yutaka ^c  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gunma Psychiatric Medical Center   (Japan)

^c Sawa Hospital   (Japan)

^d Saitama Prefectural Psychiatric Hospital   (Japan)

^e Saiseikai Matsuyama Hospital   (Japan)

^f Tosa Hospital   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^h KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

ⁱ Kyoto Prefectural Rakunan Hospital   (Japan)

^j Shizuoka Psychiatric Medical Center   (Japan)

more..

Author keywords

Aripiprazole; Clinical trial; Emergency; Olanzapine; Quetiapine; Risperidone

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AKATHISIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARKINSONISM; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 67649876113     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.05.030     Document Type: Article

References (11)

1. Guy W. ECDEU Assessment Manual for Psychopharmacology (1976), US Dept of Health, Education, and Welfare, Bethesda
2. Inada T. Evaluation and Diagnosis of Drug-induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to its Usage (1996), Seiwa Shoten Publishers, Tokyo
3. Johnsen E., and Jørgensen H.A. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry 8 (2008) 31 10.1186/1471-244X-8-31
4. Jones S.H., Thornicroft G., Coffey M., and Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br. J. Psychiatry 166 5 (1995) 654-659
5. Kahn R.S., Fleischhacker W.W., Boter H., Davidson M., Vergouwe Y., Keet I.P., Gheorghe M.D., Rybakowski J.K., Galderisi S., Libiger J., Hummer M., Dollfus S., López-Ibor J.J., Hranov L.G., Gaebel W., Peuskens J., Lindefors N., Riecher-Rössler A., Grobbee D.E., and EUFEST study group. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371 9618 (2008) 1085-1097
6. Kane J.M., Leucht S., Carpenter D., and Docherty J.P. Optimizing pharmacologic treatment of psychotic disorders. J. Clin. Psychiatry 64 suppl 12 (2003) 1-100
7. Kay S.R., Opler L.A., and Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual (1991), Multi-Health System Inc., Toronto
8. Kraus J.E., Sheitman B.B., Cook A., Reviere R., and Lieberman J.A. Olanzapine versus risperidone in newly admitted acutely ill psychotic patients. J. Clin. Psychiatry 66 12 (2005) 1564-1568
9. Leucht S., Komossa K., Rummel-Kluge C., Corves C., Hunger H., Schmid F., Asenjo Lobos C., Schwarz S., and Davis J.M. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am. J. Psychiatry 166 2 (2009) 152-163
10. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K., and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353 12 (2005) 1209-1223
11. McCue R.E., Waheed R., Urcuyo L., Orendain G., Joseph M.D., Charles R., and Hasan S.M. Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia. Br. J. Psychiatry 189 11 (2006) 433-440